Search for: "Endo Pharmaceuticals Inc. v. Sandoz Inc."
Results 1 - 20
of 31
Sort by Relevance
|
Sort by Date
8 Feb 2017, 3:09 am
Briefing: Sandoz Inc. v. [read post]
16 Jan 2017, 5:44 pm
Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
14 Nov 2016, 9:16 am
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
13 Oct 2016, 6:50 am
Fossil, Inc., et al, No. 16-202 (SCA Redux plus TM issue) Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
28 Sep 2016, 8:39 am
Momenta Pharmaceuticals, Inc., et al., No. 15-1402 (scope of 271(e) safe harbor) Post Grant Admin: Ethicon Endo-Surgery, Inc. v. [read post]
28 Jun 2016, 6:41 am
(post-sale restrictions); and Sandoz v. [read post]
3 Jun 2016, 6:40 am
Seagate, No. 15-1285 (pre-invention assignment of future patent rights) Biologics Notice of Commercial Marketing: Sandoz Inc. v. [read post]
18 May 2016, 8:19 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
3 May 2016, 1:42 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
18 Apr 2016, 9:58 am
Sandoz, Inc., 135 S. [read post]
1 Apr 2016, 8:22 am
Lexmark International, Inc., No. 15-1189 (unreasonable restraints on downstream uses) Obviousness: Cubist Pharmaceuticals, Inc. v. [read post]
17 Mar 2016, 2:45 am
Ethicon Endo-Surgery, Inc., No. 15-115 Nautilus, Inc. v. [read post]
4 Mar 2016, 12:25 pm
Apotex Inc., No. 15-281 Mylan Pharmaceuticals Inc. v. [read post]
23 Dec 2013, 5:16 am
Sandoz Inc., 921 F. [read post]
24 Aug 2011, 12:33 am
: AMP v USPTO (Patent Docs) US: WFU law professor says Federal Circuit failed as “keeper of the Constitution” in AMP v. [read post]
2 Jun 2011, 12:46 pm
Ortho Pharmaceutical Corp., 661 N.E.2d 352, 354 (Ill. 1996); Frye v. [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
16 Jun 2010, 3:02 pm
Sandoz, Inc. [read post]
10 Jun 2010, 3:58 am
Par Pharmaceutical, Inc. [read post]
7 Apr 2010, 4:30 am
Sandoz Pharmaceuticals GmbH et al (EPLAW) Prilosec (Omeprazole) – US: AstraZeneca ordered to pay attorney’s fees for ‘baseless’ suit to protect Prilosec OTC: AstraZeneca AB et al. v. [read post]
